Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock () or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Home Seeking Victim Information on CBA Pharma Inc

Seeking Victim Information on CBA Pharma Inc

Seeking Victim Information on CBA Pharma Inc

The FBI’s Louisville Division, Lexington Resident Agency, is investigating CBA Pharma Inc. in a joint investigation with the Food and Drug Administration (FDA) Office of Criminal Investigations (OCI) and the Kentucky Department of Financial Institutions. Records obtained through this investigation have identified you and/or your company as a possible victim of wire fraud, securities fraud, and other federal crimes.

Contact Information
Date of Birth  
/ /  
2. Did you, your business, or your organization ever invest money into CBA Pharma, Inc.?  

4. If your answer to Question 2 was “Yes,” how were funds provided to CBA Pharma? Mark all that apply:
7. Did you receive information about CBA Pharma’s Royalty Offering?  

8. Did you invest money into CBA Pharma’s Royalty Offering?  

11. Have you ever received a product called Brightstar from CBA Pharma?  

12. If your answer to Question 11 was “Yes,” did you receive any direction on Brightstar’s use?

Privacy Act Statement

The FBI is authorized to collect the information on this form by one or more of the following provisions: Title 28, United States Code, sections 533 and 534; Title 28, Code of Federal Regulations, section 0.85; and the Attorney General Guidelines for Victim and Witness Assistance. The information requested will assist the FBI in providing you with assistance to which crime victims are entitled under federal law. You do not have to provide the requested information; however, failure to do so may hinder the FBI in providing you with crime victim assistance. The information collected on this form is protected by the Privacy Act of 1974, as amended, Title 5, United States Code section 552a, and is maintained in the FBI’s Central Records System, DOJ/FBI-002, a description of which was published in the Federal Register at 63 Fed. Reg. 8671 (Feb. 20, 1998) and which may be viewed at